Toshitaka Yajima

2.7k total citations
65 papers, 2.0k citations indexed

About

Toshitaka Yajima is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Toshitaka Yajima has authored 65 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cardiology and Cardiovascular Medicine, 18 papers in Endocrinology, Diabetes and Metabolism and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Toshitaka Yajima's work include Diabetes Treatment and Management (18 papers), Potassium and Related Disorders (15 papers) and Diabetes Management and Research (10 papers). Toshitaka Yajima is often cited by papers focused on Diabetes Treatment and Management (18 papers), Potassium and Related Disorders (15 papers) and Diabetes Management and Research (10 papers). Toshitaka Yajima collaborates with scholars based in Japan, United States and Sweden. Toshitaka Yajima's co-authors include Kirk U. Knowlton, Nancy D. Dalton, Suguru Okami, Dingding Xiong, Yusu Gu, Kirk L. Peterson, Ju Chen, Shun Kohsaka, Eiichiro Kanda and Hideo Yasukawa and has published in prestigious journals such as Science, Journal of Biological Chemistry and Circulation.

In The Last Decade

Toshitaka Yajima

63 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toshitaka Yajima Japan 25 1.0k 756 388 221 213 65 2.0k
Manfred Schuster Austria 23 945 0.9× 835 1.1× 537 1.4× 164 0.7× 321 1.5× 35 2.5k
Kai Kappert Germany 29 369 0.4× 1.0k 1.3× 236 0.6× 303 1.4× 483 2.3× 98 2.3k
Monica V. Talor United States 29 799 0.8× 462 0.6× 347 0.9× 299 1.4× 862 4.0× 77 2.4k
Hideki Oka Japan 18 338 0.3× 692 0.9× 144 0.4× 338 1.5× 124 0.6× 87 1.8k
Jan Menne Germany 25 399 0.4× 1.2k 1.6× 316 0.8× 378 1.7× 664 3.1× 68 3.2k
Fiona J. Warner Australia 20 609 0.6× 524 0.7× 457 1.2× 242 1.1× 134 0.6× 37 2.1k
Éric Frisdal France 26 297 0.3× 467 0.6× 294 0.8× 599 2.7× 180 0.8× 46 1.7k
Mark Luedde Germany 24 501 0.5× 1.5k 2.0× 154 0.4× 264 1.2× 357 1.7× 76 2.6k
Jacques Bonnet France 32 1.0k 1.0× 2.0k 2.7× 206 0.5× 605 2.7× 277 1.3× 112 3.9k
Marta Riera Spain 28 346 0.3× 428 0.6× 288 0.7× 381 1.7× 138 0.6× 77 1.9k

Countries citing papers authored by Toshitaka Yajima

Since Specialization
Citations

This map shows the geographic impact of Toshitaka Yajima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshitaka Yajima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshitaka Yajima more than expected).

Fields of papers citing papers by Toshitaka Yajima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshitaka Yajima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshitaka Yajima. The network helps show where Toshitaka Yajima may publish in the future.

Co-authorship network of co-authors of Toshitaka Yajima

This figure shows the co-authorship network connecting the top 25 collaborators of Toshitaka Yajima. A scholar is included among the top collaborators of Toshitaka Yajima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshitaka Yajima. Toshitaka Yajima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akiyama, Hiroki, et al.. (2023). Evolution of sodium-glucose co-transporter 2 inhibitors from a glucose-lowering drug to a pivotal therapeutic agent for cardio-renal-metabolic syndrome. Frontiers in Endocrinology. 14. 1111984–1111984. 12 indexed citations
2.
Kanda, Eiichiro, et al.. (2023). Impact of chronic potassium binder treatment on the clinical outcomes in patients with hyperkalemia: Results of a nationwide hospital-based cohort study. Frontiers in Physiology. 14. 1156289–1156289. 1 indexed citations
3.
Iwagami, Masao, et al.. (2023). Association of Hyperkalemia and Hypokalemia with Patient Characteristics and Clinical Outcomes in Japanese Hemodialysis (HD) Patients. Journal of Clinical Medicine. 12(6). 2115–2115. 3 indexed citations
4.
Kanda, Eiichiro, Anjay Rastogi, Toyoaki Murohara, et al.. (2023). Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia. BMC Nephrology. 24(1). 18–18. 26 indexed citations
5.
6.
7.
Kanda, Eiichiro, et al.. (2022). Machine learning models for prediction of HF and CKD development in early-stage type 2 diabetes patients. Scientific Reports. 12(1). 20012–20012. 13 indexed citations
8.
Kohsaka, Shun, Suguru Okami, Eiichiro Kanda, Naoki Kashihara, & Toshitaka Yajima. (2021). Cardiovascular and Renal Outcomes Associated With Hyperkalemia in Chronic Kidney Disease: A Hospital-Based Cohort Study. SHILAP Revista de lepidopterología. 5(2). 274–285. 16 indexed citations
9.
Takahara, Mitsuyoshi, Tomoya Mita, Naoto Katakami, et al.. (2021). Three-Year Glycaemic Control and Management in Patients with Type 2 Diabetes Initiating Second-Line Treatment in Japan: A Prospective Observational Study, J-DISCOVER. Diabetes Therapy. 13(2). 251–264. 5 indexed citations
10.
Kashihara, Naoki, Yoshimitsu Yamasaki, Takeshi Osonoi, et al.. (2020). A phase 3 multicenter open-label maintenance study to investigate the long-term safety of sodium zirconium cyclosilicate in Japanese subjects with hyperkalemia. Clinical and Experimental Nephrology. 25(2). 140–149. 12 indexed citations
11.
Kashihara, Naoki, Shun Kohsaka, Eiichiro Kanda, Suguru Okami, & Toshitaka Yajima. (2019). Hyperkalemia in Real-World Patients Under Continuous Medical Care in Japan. Kidney International Reports. 4(9). 1248–1260. 61 indexed citations
12.
Yokoyama, Tadashi, Akihiko Ohta, Satoshi Motoya, et al.. (2017). Efficacy and Safety of Oral Budesonide in Patients with Active Crohn's Disease in Japan: A Multicenter, Double-Blind, Randomized, Parallel-Group Phase 3 Study. Inflammatory Intestinal Diseases. 2(3). 154–162. 13 indexed citations
13.
Sheikh, Farah, Stephan Lange, Andrea A. Domenighetti, et al.. (2008). An FHL1-containing complex within the cardiomyocyte sarcomere mediates hypertrophic biomechanical stress responses in mice. Journal of Clinical Investigation. 118(12). 3870–3880. 193 indexed citations
14.
Xiong, Dingding, Andrea Dörner, Tae‐Jin Youn, et al.. (2008). Coxsackievirus and adenovirus receptor (CAR) mediates atrioventricular-node function and connexin 45 localization in the murine heart. Journal of Clinical Investigation. 118(8). 2758–2770. 109 indexed citations
15.
Trifilo, Matthew J., Toshitaka Yajima, Yusu Gu, et al.. (2006). Prion-Induced Amyloid Heart Disease with High Blood Infectivity in Transgenic Mice. Science. 313(5783). 94–97. 49 indexed citations
16.
Kurihashi, Akira, Toshitaka Yajima, Tsuyoshi Shiga, et al.. (2004). Echocardiographic characteristics predicting efficacy of drug therapy in patients with hypertrophic obstructive cardiomyopathy. International Journal of Cardiology. 98(1). 141–145.
17.
Yajima, Toshitaka, Tadahito Kanda, Kunito Yoshiike, & Yoshihiro Kitamura. (1998). Retroviral Vector Targeting Human Cells via c-Kit–Stem Cell Factor Interaction. Human Gene Therapy. 9(6). 779–787. 25 indexed citations
18.
Yajima, Toshitaka, Hirotaka Nagashima, Nobuhisa Hagiwara, et al.. (1997). Functional activity of the CFTR Cl− channel in human myocardium. Heart and Vessels. 12(6). 255–261. 10 indexed citations
19.
Shoji, Tasuku, Shigeo Tanaka, Masatoshi Ikeshita, et al.. (1994). Clinical Evaluation of a New Type of Centrifugal Pump. Artificial Organs. 18(9). 702–705. 9 indexed citations
20.
Yajima, Toshitaka, Masatoshi Ikeshita, & T Shoji. (1990). [The effect of chemical ablation with lugol solution for ventricular tachyarrhythmia on cardiac function].. PubMed. 38(12). 2409–15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manfred Schuster Breakdown of academic impact, for papers by Kai Kappert Breakdown of academic impact, for papers by Monica V. Talor Breakdown of academic impact, for papers by Hideki Oka Breakdown of academic impact, for papers by Jan Menne Breakdown of academic impact, for papers by Fiona J. Warner Breakdown of academic impact, for papers by Éric Frisdal Breakdown of academic impact, for papers by Mark Luedde Breakdown of academic impact, for papers by Jacques Bonnet Breakdown of academic impact, for papers by Marta Riera
Rankless by CCL
2026